• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

打破环境影响疾病的模式以降低健康风险:免疫视角。

Breaking patterns of environmentally influenced disease for health risk reduction: immune perspectives.

机构信息

Department of Microbiology and Immunology, College of Veterinary Medicine, Cornell University, Ithaca, New York, USA.

出版信息

Environ Health Perspect. 2010 Aug;118(8):1091-9. doi: 10.1289/ehp.1001971. Epub 2010 May 18.

DOI:10.1289/ehp.1001971
PMID:20483701
原文链接:https://pmc.ncbi.nlm.nih.gov/articles/PMC2920092/
Abstract

BACKGROUND

Diseases rarely, if ever, occur in isolation. Instead, most represent part of a more complex web or "pattern" of conditions that are connected via underlying biological mechanisms and processes, emerge across a lifetime, and have been identified with the aid of large medical databases.

OBJECTIVE

We have described how an understanding of patterns of disease may be used to develop new strategies for reducing the prevalence and risk of major immune-based illnesses and diseases influenced by environmental stimuli.

FINDINGS

Examples of recently defined patterns of diseases that begin in childhood include not only metabolic syndrome, with its characteristics of inflammatory dysregulation, but also allergic, autoimmune, recurrent infection, and other inflammatory patterns of disease. The recent identification of major immune-based disease patterns beginning in childhood suggests that the immune system may play an even more important role in determining health status and health care needs across a lifetime than was previously understood.

CONCLUSIONS

Focusing on patterns of disease, as opposed to individual conditions, offers two important venues for environmental health risk reduction. First, prevention of developmental immunotoxicity and pediatric immune dysfunction can be used to act against multiple diseases. Second, pattern-based treatment of entryway diseases can be tailored with the aim of disrupting the entire disease pattern and reducing the risk of later-life illnesses connected to underlying immune dysfunction. Disease-pattern-based evaluation, prevention, and treatment will require a change from the current approach for both immune safety testing and pediatric disease management.

摘要

背景

疾病很少是孤立发生的。相反,大多数疾病代表了更复杂的“模式”的一部分,这些模式通过潜在的生物学机制和过程相互关联,在一生中出现,并借助大型医学数据库得以识别。

目的

我们描述了如何利用对疾病模式的理解来制定新策略,以降低主要基于免疫的疾病和受环境刺激影响的疾病的患病率和风险。

发现

最近定义的一些始于儿童期的疾病模式的例子不仅包括代谢综合征,其特征是炎症失调,还包括过敏、自身免疫、反复感染和其他炎症性疾病模式。最近发现始于儿童期的主要基于免疫的疾病模式表明,免疫系统在决定一生中的健康状况和医疗需求方面可能比以前理解的更为重要。

结论

关注疾病模式而不是个别病症为减少环境健康风险提供了两个重要途径。首先,预防发育性免疫毒性和儿科免疫功能障碍可以用于对抗多种疾病。其次,基于模式的入口疾病治疗可以定制,目的是破坏整个疾病模式并降低与潜在免疫功能障碍相关的晚年疾病风险。基于疾病模式的评估、预防和治疗将需要改变当前的免疫安全性测试和儿科疾病管理方法。

https://cdn.ncbi.nlm.nih.gov/pmc/blobs/89d2/2920092/bde2671ba057/ehp.1001971f5.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/89d2/2920092/b799b77d1273/ehp.1001971f1.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/89d2/2920092/ac157818b3d0/ehp.1001971f2.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/89d2/2920092/e7d084f2d3bd/ehp.1001971f3.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/89d2/2920092/465b3af80d34/ehp.1001971f4.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/89d2/2920092/bde2671ba057/ehp.1001971f5.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/89d2/2920092/b799b77d1273/ehp.1001971f1.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/89d2/2920092/ac157818b3d0/ehp.1001971f2.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/89d2/2920092/e7d084f2d3bd/ehp.1001971f3.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/89d2/2920092/465b3af80d34/ehp.1001971f4.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/89d2/2920092/bde2671ba057/ehp.1001971f5.jpg

相似文献

1
Breaking patterns of environmentally influenced disease for health risk reduction: immune perspectives.打破环境影响疾病的模式以降低健康风险:免疫视角。
Environ Health Perspect. 2010 Aug;118(8):1091-9. doi: 10.1289/ehp.1001971. Epub 2010 May 18.
2
Current status of developmental immunotoxicity: early-life patterns and testing.发育免疫毒性的现状:生命早期模式与检测
Toxicol Pathol. 2012;40(2):230-6. doi: 10.1177/0192623311427709. Epub 2011 Nov 22.
3
Identifying patterns of immune-related disease: use in disease prevention and management.识别免疫相关疾病的模式:在疾病预防和管理中的应用。
World J Pediatr. 2010 May;6(2):111-8. doi: 10.1007/s12519-010-0026-1. Epub 2010 May 21.
4
Early-life immune insult and developmental immunotoxicity (DIT)-associated diseases: potential of herbal- and fungal-derived medicinals.早年免疫损伤与发育性免疫毒性(DIT)相关疾病:草药和真菌衍生药物的潜力
Curr Med Chem. 2007;14(10):1075-85. doi: 10.2174/092986707780362899.
5
Approaches and considerations for the assessment of immunotoxicity for environmental chemicals: a workshop summary.环境化学品免疫毒性评估的方法与考量:研讨会总结
Regul Toxicol Pharmacol. 2014 Feb;68(1):96-107. doi: 10.1016/j.yrtph.2013.11.012. Epub 2013 Nov 23.
6
Role of developmental immunotoxicity and immune dysfunction in chronic disease and cancer.发育免疫毒性和免疫功能障碍在慢性病和癌症中的作用。
Reprod Toxicol. 2011 Apr;31(3):319-26. doi: 10.1016/j.reprotox.2010.09.006. Epub 2010 Sep 18.
7
Breaking patterns of disease: early-life clues may predict long-term health.打破疾病模式:生命早期线索可能预测长期健康状况。
Environ Health Perspect. 2010 Aug;118(8):a352. doi: 10.1289/ehp.118-2920107.
8
Developmental Exposure to Environmental Chemicals and Metabolic Changes in Children.儿童发育期接触环境化学物质与代谢变化
Curr Probl Pediatr Adolesc Health Care. 2016 Aug;46(8):255-85. doi: 10.1016/j.cppeds.2016.06.001. Epub 2016 Jul 9.
9
Developmental immunotoxicity (DIT) in drug safety testing: matching DIT testing to adverse outcomes and childhood disease risk.药物安全性测试中的发育免疫毒性(DIT):使DIT测试与不良后果及儿童疾病风险相匹配。
Curr Drug Saf. 2008 Sep;3(3):216-26. doi: 10.2174/157488608785699450.
10
Insulin resistance and environmental pollutants: experimental evidence and future perspectives.胰岛素抵抗与环境污染物:实验证据与未来展望。
Environ Health Perspect. 2013 Nov-Dec;121(11-12):1273-81. doi: 10.1289/ehp.1307082. Epub 2013 Sep 20.

引用本文的文献

1
Guardians under Siege: Exploring Pollution's Effects on Human Immunity.守护者遭遇围攻:探索污染对人类免疫的影响。
Int J Mol Sci. 2024 Jul 16;25(14):7788. doi: 10.3390/ijms25147788.
2
Public Health Risks of PFAS-Related Immunotoxicity Are Real.PFAS 相关免疫毒性的公共健康风险是真实存在的。
Curr Environ Health Rep. 2024 Jun;11(2):118-127. doi: 10.1007/s40572-024-00441-y. Epub 2024 Mar 25.
3
Dietary Approaches from Moms, Farms, and Nature to Overcome Chronic Diseases and the Pharmacracy.从妈妈、农场和大自然的饮食方法来克服慢性疾病和药物滥用。

本文引用的文献

1
Role of developmental immunotoxicity and immune dysfunction in chronic disease and cancer.发育免疫毒性和免疫功能障碍在慢性病和癌症中的作用。
Reprod Toxicol. 2011 Apr;31(3):319-26. doi: 10.1016/j.reprotox.2010.09.006. Epub 2010 Sep 18.
2
Identifying patterns of immune-related disease: use in disease prevention and management.识别免疫相关疾病的模式:在疾病预防和管理中的应用。
World J Pediatr. 2010 May;6(2):111-8. doi: 10.1007/s12519-010-0026-1. Epub 2010 May 21.
3
Innate immunity and adipose tissue biology.先天免疫与脂肪组织生物学。
Nutrients. 2023 Sep 14;15(18):3965. doi: 10.3390/nu15183965.
4
Alterations in Microbial-Associated Fecal Metabolites in Relation to Arsenic Exposure Among Infants.婴儿中与砷暴露相关的微生物粪便代谢物变化
Expo Health. 2022 Dec;14(4):941-949. doi: 10.1007/s12403-022-00468-2. Epub 2022 Feb 3.
5
Individual blood concentrations of persistent organic pollutants and chemical elements, and COVID-19: A prospective cohort study in Barcelona.个体血液中持久性有机污染物和化学元素浓度与 COVID-19 的关系:巴塞罗那的一项前瞻性队列研究。
Environ Res. 2023 Apr 15;223:115419. doi: 10.1016/j.envres.2023.115419. Epub 2023 Feb 4.
6
Invited Perspective: Key Characteristics as a Starting Point for Improved Hazard Identification of Immunotoxic Agents.特邀观点:关键特征作为改进免疫毒性剂危害识别的起点。
Environ Health Perspect. 2022 Oct;130(10):101301. doi: 10.1289/EHP11726. Epub 2022 Oct 6.
7
Using Microbiome-Based Approaches to Deprogram Chronic Disorders and Extend the Healthspan following Adverse Childhood Experiences.利用基于微生物组的方法逆转慢性疾病并在童年不良经历后延长健康寿命。
Microorganisms. 2022 Jan 21;10(2):229. doi: 10.3390/microorganisms10020229.
8
Microbiome First Medicine in Health and Safety.健康与安全领域的微生物群优先医学。
Biomedicines. 2021 Aug 27;9(9):1099. doi: 10.3390/biomedicines9091099.
9
Current EU regulatory requirements for the assessment of chemicals and cosmetic products: challenges and opportunities for introducing new approach methodologies.当前欧盟化学品和化妆品评估的监管要求:引入新方法学的挑战和机遇。
Arch Toxicol. 2021 Jun;95(6):1867-1897. doi: 10.1007/s00204-021-03034-y. Epub 2021 Apr 13.
10
Role of Immune and Autoimmune Dysfunction in Schizophrenia.免疫与自身免疫功能障碍在精神分裂症中的作用
Handb Behav Neurosci. 2016;23:501-516. doi: 10.1016/B978-0-12-800981-9.00029-8. Epub 2015 Nov 10.
Trends Immunol. 2010 Jun;31(6):228-35. doi: 10.1016/j.it.2010.03.001.
4
The metabolic syndrome - an ongoing story.代谢综合征——一个持续的故事。
J Physiol Pharmacol. 2009 Dec;60 Suppl 7:19-24.
5
Increased risk of chronic kidney disease in elderly with metabolic syndrome and high levels of C-reactive protein: Kahrizak Elderly Study.代谢综合征且 C 反应蛋白水平较高的老年人患慢性肾脏病风险增加:卡里扎克老年人研究。
Kidney Blood Press Res. 2009;32(6):457-63. doi: 10.1159/000274046.
6
Immune modulation of blood-derived stem cell as a comprehensive tool for treating type 1 diabetes.血液来源干细胞的免疫调节作为治疗1型糖尿病的综合工具。
Discov Med. 2009 Dec;8(43):219-22.
7
The 2009 stock conference report: inflammation, obesity and metabolic disease.2009 年股票会议报告:炎症、肥胖和代谢性疾病。
Obes Rev. 2010 Sep;11(9):635-44. doi: 10.1111/j.1467-789X.2009.00691.x.
8
Developmental immunotoxicity (DIT): the why, when, and how of DIT testing.发育免疫毒性(DIT):DIT测试的原因、时间及方式
Methods Mol Biol. 2010;598:17-25. doi: 10.1007/978-1-60761-401-2_2.
9
Association between stroke and metabolic syndrome in a Japanese population: Jichi Medical School (JMS) Cohort Study.日本人群中卒中与代谢综合征的关联:ichi 医科大学(JMS)队列研究。
J Epidemiol. 2010;20(1):62-9. doi: 10.2188/jea.je20081041. Epub 2009 Dec 5.
10
TNF-alpha inhibits insulin action in liver and adipose tissue: A model of metabolic syndrome.肿瘤坏死因子-α抑制肝和脂肪组织中胰岛素的作用:代谢综合征模型。
Horm Metab Res. 2010 Feb;42(2):115-21. doi: 10.1055/s-0029-1241834. Epub 2009 Dec 3.